Publish in this journal
Journal Information
Vol. 74. Issue 3.
Pages 280-281 (March 2021)
Vol. 74. Issue 3.
Pages 280-281 (March 2021)
Letter to the Editor
Full text access
Cardiac involvement in COVID-19: does echocardiography matter?
Afección cardiaca por COVID-19, ¿importa la ecocardiografía?
Pablo Jorge-Péreza,
Corresponding author

Corresponding author:
, Albert Durán-Cambrab
a Unidad de Cuidados Agudos Cardiológicos, Servicio de Cardiología, Complejo Hospitalario Universitario de Canarias, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain
b Unidad de Cuidados Agudos Cardiológicos, Servicio de Cardiología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Related content
Rev Esp Cardiol. 2020;73:861-310.1016/j.rec.2020.06.030
Miguel Rodríguez-Santamarta, Carlos Minguito-Carazo, Julio César Echarte-Morales, Samuel Del Castillo-García, Jorge Valdivia-Ruiz, Felipe Fernández-Vázquez
Rev Esp Cardiol. 2021;74:28110.1016/j.rec.2020.11.010
Miguel Rodríguez-Santamarta, Carlos Minguito-Carazo, Julio Echarte-Morales, Samuel Del Castillo-García
This item has received
Article information
Full Text
Download PDF
Full Text
To the Editor,

After attentively reading the article by Rodríguez-Santamarta et al.,1 we would like to provide some considerations regarding echocardiography for critically ill patients with 2019 coronavirus disease (COVID-19).

In the analysis of their patient series, the authors found no association between systolic dysfunction (left ventricular ejection fraction <50%) and a poor prognosis. These results led them to propose limiting echocardiography studies to patients with congestive heart failure, arrhythmias, electrocardiographic changes, or cardiomegaly.

First, we wish to congratulate the group for an interesting and important study carried out in these difficult times of the COVID-19 pandemic. This situation has created a new scenario requiring constant efforts of adaptation, and studies such as this enable advances in the knowledge and treatment of this disease.

In our opinion, the results provided should be analyzed with caution, as the study contains a small, single-center sample and the results contrast with those reported in previous articles on COVID-19 patients in intensive care units. In these studies, elevated biomarkers of myocardial injury and stress, such as cardiac troponin and the amino-terminal fraction of pro-brain natriuretic peptide, and a lower left ventricular ejection fraction were associated with a worse prognosis.2,3

Of note, cardiac involvement in these patients is not limited to changes in left ventricular systolic function, the variable analyzed in association with the prognosis in the study. It seems that right ventricular dilation and dysfunction are even more common,4 likely resulting from increased pulmonary vascular resistance due to alveolar hypoxia and possible thromboembolic phenomena.

Echocardiography, and more recently lung ultrasound, are first-line tests in the assessment of critically ill patients because of their wide availability and high diagnostic yield. We agree that it is important to balance the indication and benefits of conducting these studies when there is a potential risk of disease transmission, and in this regard, critically ill patient deserves special consideration.

There is a non-negligible prevalence of cardiac dysfunction and myocardial injury in intensive care unit patients with COVID-19, as many have various underlying heart conditions (right ventricular systolic dysfunction and dilation or systolic and diastolic left ventricular dysfunction) that require different clinical treatments. Echocardiography findings can imply a treatment change in up to 33% of these patients.5

Furthermore, in addition to assessing biventricular function (and the presence or absence of pericardial effusion), echocardiography provides other useful information, such as noninvasive estimation of cardiac output, diastolic function parameters—in particular the E/e’ ratio—and evaluation of right ventricular function and the pulmonary circulation, which is of considerable value in patients with severe hypoxemia requiring mechanical ventilation. Interpreting this set of parameters is helpful for the treatment of critically ill COVID-19 patients regarding aspects such as optimizing positive end-expiratory pressure and progressing to successful weaning from mechanical ventilation.6,7

Moreover, as there is a known relationship between COVID-19 and thromboembolic phenomena, ultrasound study can be useful to promptly recognize possible thromboembolic complications of the disease.8

Finally, ultrasound of the lung complements lung function study by enabling detection of pulmonary interstitial edema, subpleural consolidations, atelectasis, pneumothorax, and pleural effusion. In certain cases, it can obviate referrals for computed tomography examination, with a consequent decrease in the risk of contagion.9

In conclusion, in situations of elevated disease transmission, we should consider the balance between the risk of contagion and the expected clinical benefit of complementary examinations. Myocardial injury is common in critically ill patients with COVID-19, and echocardiography is important for diagnosing and treating these patients.

M. Rodríguez-Santamarta, C. Minguito-Carazo, J.C. Echarte-Morales, S. Del Castillo-García, J. Valdivia-Ruiz, F. Fernández-Vázquez.
Echocardiographic findings in critical patients with COVID-19.
Rev Esp Cardiol., 73 (2020), pp. 861-863
S. Shi, M. Qin, B. Shen, et al.
Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan.
China. JAMA Cardiol., 5 (2020), pp. 802-810
Q. Deng, B. Hu, Y. Zhang, et al.
Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan.
China. Int J Cardiol., 311 (2020), pp. 116-121
Y. Szekely, Y. Lichter, P. Taieb, et al.
Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study.
Circulation., 142 (2020), pp. 342-353
M.R. Dweck, A. Bularga, R.T. Hahn, et al.
Global evaluation of echocardiography in patients with COVID-19.
Eur Heart J Cardiovasc Imaging., 21 (2020), pp. 949-958
L. Zhang, B. Wang, J. Zhou, et al.
Bedside focused cardiac ultrasound in COVID-19 from the Wuhan epicenter: the role of cardiac point-of-care ultrasound, limited transthoracic echocardiography, and critical care echocardiography.
J Am Soc Echocardiogr., 33 (2020), pp. 676-682
D.H. Drake, M. De Bonis, M. Covella, et al.
Echocardiography in pandemic: front-line perspective, expanding role of ultrasound, and ethics of resource allocation.
J Am Soc Echocardiogr., 33 (2020), pp. 683-689
V. Fraile Gutiérrez, J.M. Ayuela Azcárate, D. Pérez-Torres, L. Zapata, A. Rodríguez Yakushev, A. Ochagavía.
Ultrasound in the management of the critically ill patient with SARS-CoV-2 infection (COVID-19): narrative review.
Med Intensiva., 44 (2020), pp. 551-565
M. Cameli, M.C. Pastore, M. Henein, et al.
Safe performance of echocardiography during the COVID-19 pandemic: a practical guide.
Rev Cardiovasc Med., 21 (2020), pp. 217-223
Copyright © 2020. Sociedad Española de Cardiología
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

View newsletter history
Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?